je.st
news
Tag: therapeutics
Impax Laboratories acquires Tower Holdings and Lineage Therapeutics
2015-03-10 16:40:34| Biotech - Topix.net
Impax Laboratories, Inc. today announced that it has completed its acquisition of Tower Holdings, Inc. , and Lineage Therapeutics Inc. . In connection with the closing of the acquisition, Impax also announced that it is reshaping the operating and reporting structure of its two divisions the Impax generic products division will now be known as "Impax Generics" and the Impax branded products division will now be known as "Impax Specialty Pharma".
Tags: tower
holdings
laboratories
lineage
Phico Therapeutics gets A 2.25M Translation Award to develop SASPject ...
2015-03-09 12:33:20| Biotech - Topix.net
Phico Therapeutics, a biotechnology company developing a novel platform technology for a new generation of antibiotics aimed at overcoming antibacterial resistance, has been awarded a 2.25M Translation Award by the Wellcome Trust to develop its SASPject PT4 antibiotic, aimed at Escherichia coli and Klebsiella pneumonia e . SASPject 's PT4 is targeted at E. coli and K. pneumoniae , including multi-drug resistant strains.
Tags: develop
award
translation
therapeutics
Frost & Sullivan Applauds Neopeutics' Commitment To Accelerating The Delivery Of New Nature-Based Pharmaceuticals And Therapeutics
2015-03-04 05:15:30| drugdiscoveryonline Home Page
Based on its recent analysis of the enhanced drug discovery market, Frost & Sullivan recognizes Neopeutics, Inc. with the 2015 North America Frost & Sullivan Award for Technology Leadership
Tags: delivery
commitment
sullivan
frost
NGM And Merck Announce Broad Strategic Collaboration To Discover, Develop And Commercialize Novel Biologic Therapeutics
2015-03-04 04:25:06| drugdiscoveryonline News Articles
NGM Biopharmaceuticals, Inc., a privately-held biotechnology company and Merck, known as MSD outside the United States and Canada, recently announced they have entered into a multi-year collaboration to research, discover, develop and commercialize novel biologic therapies across a wide range of therapeutic areas
Tags: develop
broad
discover
collaboration
Investors short Juno Therapeutics, Amgen stocks, but that may not be bad news
2015-03-03 04:12:21| Biotech - Topix.net
More investors were shorting their biotech stocks in the first half of February than in the previous month, according to financial news site Benzinga . Of the top three companies with the most short sells, two have Puget Sound ties: Seattle-based Juno Therapeutics and California-based Amgen , which has offices in Bothell and Seattle until the end of the year.
Sites : [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] next »